Inter-connecting health problems increase HIV risk for MSM

Intertwining health problems – syndemics – are associated with higher viral load and poorer adherence in HIV-positive men who have sex with men (MSM) taking antiretroviral treatment (ART), investigators from the United States report in the online edition of AIDS.

“Higher HIV viral load and lower ART adherence are, respectively, associated with increased syndemics count,” explain the authors. “These findings indicate that combinations of depression symptoms, polysubstance use and sexual risk behaviour function as profound barriers to fully reaping the benefits of successful HIV care and that, as these conditions snowball, their impact on HIV outcomes is exacerbated.”

They believe their findings have important implications for current treatment as prevention strategies to control the HIV epidemic, as every increase in the number of epidemics was associated with higher viral load and therefore transmission risk.

Men who have sex with men account for approximately two-thirds of new HIV diagnoses in the United States. There are great hopes that the use of antiretroviral treatment as prevention will help curtail the epidemic in this population. However, only 28% of people with HIV in the US have an undetectable viral load.

Investigators from the Multicentre AIDS Cohort Study (MACS) were concerned that there were significant barriers preventing MSM with HIV from achieving and maintaining an undetectable viral load.

It is possible that syndemics (intertwining health problems) such as adversity and trauma in early life are associated with depression and substance abuse in young adulthood, which in turn leads to sexual risk-taking.

To see if this is the case, investigators assessed the association of syndemics on adherence and viral load in 766 MSM living with HIV who received care between 2003 and 2009.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below